Concurrent Investment Advisors »

Fibrobiologics shares owned by Concurrent Investment Advisors

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Concurrent Investment Advisors from 13F filings

Historical chart of Concurrent Investment Advisors investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Concurrent Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Concurrent Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $109k 35k 3.09
2024-06-30 $176k 35k 4.99

More positions owned by Concurrent Investment Advisors

Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Vanguard Index Fds Value Etf (VTV)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
First Tr Exchange-traded Dorsey Wrt 5 Etf (FV)

View all positions for Concurrent Investment Advisors

Top funds holding Fibrobiologics

BlackRock
BlackRock
Geode Capital Management
State Street Corporation
Cascade Financial Partners
Vanguard Group
Northern Trust
Optivise Advisory Services
Requisite Capital Management
Bank of America Corporation
American Institute for Advanced Investment Management
Charles Schwab Investment Management
Advisor Group Holdings
HPM Partners
Bank of New York Mellon

View all funds holding Fibrobiologics